MedicineEngineering

Ina Ersing, Meghan Rego, Chen Wang, Yijun Zhang, Kate Harten DeMaio, Michelle Tillgren, A. Fava, Gabrielle Clouse, Marcella Patrick, Karen Guerin, Melina Fan

2023.2.7Neuromethods

DOI: 10.1007/978-1-0716-2918-5_5

tlooto Summary

This protocol describes some of the characterization and quality control assays necessary to confirm an AAV vector’s titer, genomic identity, serotype and purity.

Abstract

Adeno-associated viral vectors (AAV) are frequently used by neuroscientists to deliver tools, such as biosensors and optogenetic and chemogenetic actuators, in vivo. Despite its widespread use, AAV vector characterization and quality control can vary between labs and viral vector cores leading to variable results and irreproducibility. This protocol describes some of the characterization and quality control assays necessary to confirm an AAV vector’s titer, genomic identity, serotype and purity.

Citation format

ERSING, Ina, et al. Quality control for adeno-associated viral vector production. Neuromethods, 2023, 195: 77–101.